View drug registration information details.


ItemsRegistration information
ID351
No351
Brand NameLENVACARE 4
IngredientsLENVATINIB 4 MG
Dosage FormCAPSULE
Primary PackagingBOTTLE
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 30'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsAS MONOTHERAPY FOR THE TREATMENT OF ADULT PATIENTS WITH PROGRESSIVE, LOCALLY ADVANCED OR METASTATIC DIFFERENTIATED THYROIDCARCINIMA, REFRACTORY TO RADIOACTIVE IODINE. AS MONOTHERAPY FOR THE TREATMENT OF ADULT PATIENTS WITH ADVANCED OR UNRESECTABLE HEPATOCELLULAR CARCINOMA WHO HAVE RECEIVED NO PRIOR SYSTEMIC THERAPY
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionCAPSULE CONTAINS WHITE POWDER
Note
License OwnerBOTEN ELEMENTO PHARMA FACTORY
ManufacturerBOTEN ELEMENTO PHARMA FACTORY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 L 0850/21
FDD Registration Date20-FEB-2025
Expiry Date19-FEB-2030

Back to drug list

 
© 2014 ສະຫງວນລິຂະສິດໂດຍ ກົມອາຫານ ແລະ ຢາ, ກະຊວງສາທາລະນະສຸກ, ສປປລາວ.
ຕິດຕໍ່ ກອຢ      ອີເມວ      ເຂົ້າລະບົບ